This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study.
THURSDAY, July 25, 2024 -- The bird flu is now jumping between species of mammals, a step that draws the virus closer to hopping into human beings, a new study warns.Researchers have tracked transmission of avian influenza between dairy cows in.
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.
THURSDAY, July 25, 2025 -- Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.These dual-action antibiotics, called macrolones, disrupt.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Engineers discovered that when the aluminum in soda cans is purified and mixed with seawater, the solution produces hydrogen -- which can power an engine or fuel cell without generating carbon emissions. The reaction can be sped up by adding caffeine.
Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.
Researchers have developed somersaulting spin qubits for universal quantum logic. This achievement may enable efficient control of large semiconductor qubit arrays. The research group recently published their demonstration of hopping spins and somersaulting spins.
THURSDAY, July 25, 2024 -- Medicare Advantage plans are touted as a great alternative to traditional Medicare, offering seniors easier access to doctors, hospitals and prescription drugs.But access to a good Medicare Advantage plan relies heavily.
Over the last century, a once-deadly mosquito-borne virus has evolved so that it no longer sickens humans. New research shows that changes in the virus's ability to target human cells paralleled the decline in illness and death. The findings offer important lessons in virology that may help guide better preparedness for future outbreaks of other viral diseases.
THURSDAY, July 25, 2024 -- Obese kids infected with dengue are significantly more likely to suffer severe illness requiring hospitalization, a new study warns.A new analysis of nearly 5,000 dengue-infected Sri Lankan children found that weight.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Researchers have found New Zealand's endangered flightless birds are seeking refuge in the locations where six species of moa last lived before going extinct.
THURSDAY, July 25, 2024 -- Farmers and folks living in agricultural areas may be exposed to levels of pesticides that confer cancer risks that are higher than if they smoked, new research shows.These extra risks were most pronounced for certain.
An international team of researchers has found that nitrogen emissions from fertilizers and fossil fuels have a net cooling effect on the climate. But they warn increasing atmospheric nitrogen has further damaging effects on the environment, calling for an urgent reduction in greenhouse gas emissions to halt global warming.
Inventory Search Interface: The new CDD Vault Inventory tab can be enabled by the CDD Support Team. If you wish to enable this tab in your vault please have your vault administrator contact support@collaborativedrug.com.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Danish Tycho Brahe was most famous for his contributions to astronomy. However, he also had a well-equipped alchemical laboratory where he produced secret medicines for Europe's elite.
THURSDAY, July 24, 2024 -- Millions of Americans deal with the sleep deficits brought on by sleep apnea, and many turn to one of the few treatments out there, continuous positive airway pressure (CPAP) machines.But what if new neurochemical targets.
In October 2022, astronomers were stunned by what was quickly dubbed the BOAT -- the brightest-of-all-time gamma-ray burst (GRB). Now an international science team reports that data from NASA's Fermi Gamma-ray Space Telescope reveals a feature never seen before.
THURSDAY, July 25, 2024 -- Finding yourself packing on the pounds around your waist and arms? If so, you might be at heightened risk for neurological illnesses like Alzheimer's or Parkinson's, new research suggests.There was one other physical.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Rock art explored by archaeologists in the Colombian Amazon has provided an insight into the complex relationship between the earliest settlers on the continent and the animals they encountered.
THURSDAY, July 25, 2024 -- Wildfires raging in several states and Canada are triggering air quality alerts and evacuation orders across the western parts of the United States.Smoke and haze have filled the skies in California, Oregon, Arizona.
Brachiopods were evolving in new directions but this did not turn into evolutionary success in terms of the numbers of species, researchers have found.
THURSDAY, June 25, 2024 -- For the first time in two decades, the infant mortality rate in the United States has risen, new government data shows.In a report released Thursday by the U.S. Centers for Disease Control and Prevention, researchers.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Darragh P O’Brien, Hannah BL Jones, Yuqi Shi, Franziska Guenther, Iolanda Vendrell, Rosa Viner, Paul E Brennan, Emma Mead, Tryfon Zarganes-Tzitzikas, John B Davis, Adán Pinto-Fernández, Katherine S England, Emma J Murphy, Andrew P Turnbull, Benedikt M Kessler bioRxiv 2024.07.20.604388; doi: [link] Inhibition of the mitochondrial deubiquitinating enzyme USP30 is neuroprotective and presents therapeutic opportunities for the treatment of idiopathic Parkinson’s Disease and mitophagy-related disorde
CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect.
THURSDAY, July 25, 2024 -- The Olympics are often described as a rare, once-in-a-lifetime shot at international sports glory.That may be more true for Olympic track and field competitors than other athletes, a new study reports.There appears to be.
The drug’s advancement continued what one analyst described as a “torrid” pace for Viking’s closely watched medicine, which started human testing in 2022 and could reach a Phase 3 trial next year.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content